Oral Thin Film Drugs Companies

*Disclaimer: List of key companies in no particular orderLatest Oral thin film drugs Companies Update

• 
  July 2023: New York-based pharmaceutical innovator Redwood Scientific Technologies Inc. (RSCI, OTC, PK) is pleased to announce the filing of a patent for its innovative Oral Thin Film (OTF) production technique. Redwood's dedication to advancing the pharmaceutical business through novel methods of medication administration is on full display in this patent. The newly created method redefines precision in the delivery of nano doses of active substances, meeting the rising demand for such drugs. Redwood's Oral Thin Film manufacturing system takes advantage of cutting-edge technology to ensure accurate formulation and reliable output of oral thin films. Increased bioavailability and better patient outcomes are both guaranteed by this innovation in comparison to more traditional medication administration systems.

• To develop and manufacture a proprietary oral psilocybin thin film strip for the company's clinical and commercial initiatives to evaluate in mental illness, neurological aphasia, and other conditions, Revive Therapeutics Ltd., a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce it has entered into a feasibility agreement with LTS Lohmann Therapie-Systeme AG, a leader in pharmaceutical oral thin films. Revive has positioned itself as a leader in developing new applications and methods of administering psilocybin to address medical gaps. By teaming up with LTS, Revive can move more quickly toward achieving its worldwide goals for psilocybin as a medicine. Company efforts have been directed at establishing partnerships and developing a wide range of psilocybin-based products, such as those with unique applications, formulations, oral thin film delivery, and biosynthetic psilocybin.

• Johnson & Johnson Services


• Pfizer Inc


• CURE Pharmaceutical


• Novartis AG


• LTS Lohmann Therapie-Systeme AG


• GlaxoSmithKline Plc


• Indivior Plc